安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
Tolebrutinib (SAR442168, PRN2246, BTKi'168, BTKi('168)) is an oral, CNS-penetrant, irreversible inhibitor of Bruton's tyrosine kinase (BTK) with IC50s of 0.4 nM and 0.7 nM in Ramos B cells and in HMC microglia cells, respectively.
Tolebrutinib (SAR442168, PRN2246, BTKi'168, BTKi('168)) is an oral, CNS-penetrant, irreversible inhibitor of Bruton's tyrosine kinase (BTK) with IC50s of 0.4 nM and 0.7 nM in Ramos B cells and in HMC microglia cells, respectively.
[1] Francesco MR, et, al. Multiple Sclerosis Journal. 2017;Poster Session 2:P989. [2] Daniel S Reich, et, al. Lancet Neurol. 2021 Sep;20(9):729-738.
动态评分
0.0